KDx Diagnostics
Nam is a seasoned scientist and executive with over 25 years of experience in developing and commercializing novel diagnostics tests at several cutting-edge biotechnology companies including Geron, and diaDexus where he was responsible for the development of novel diagnostic and prognostic markers for cancer and cardiovascular diseases.
This person is not in any offices
KDx Diagnostics
KDx Diagnostics is the developer of the Uro17™ bladder cancer test, which should be the most sensitive and specific urine test for bladder cancer detection when launched.